When one person died and four others were seriously harmed in a French drug test, Portugal-based drug maker Bial initially adopted the distancing tool known to all good writers: the passive voice. In a new Wall Street Journal “Risk and Compliance” post, she comments on what Bial did, didn’t, and should be doing.